MyFinsight
Home
Blog
About
Back
Income Statement
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)
source: myfinsight.com
Comprehensive loss
-$74,727K
(-31.49%↓ Y/Y)
Net loss
-$73,503K
(-29.86%↓ Y/Y)
Unrealized (gain) loss on
marketable securities
-$1,224K
(-434.50%↓ Y/Y)
Investment and other
income, net
$7,120K
(-1.89%↓ Y/Y)
Grant
$15K
(-97.93%↓ Y/Y)
Service
$7K
(0.00%↑ Y/Y)
Operating loss
-$80,623K
(-26.26%↓ Y/Y)
Total revenues
$22K
(-96.99%↓ Y/Y)
Total operating
expenses
$80,645K
(24.86%↑ Y/Y)
Research and development
$67,542K
(24.63%↑ Y/Y)
General and
administrative
$13,103K
(26.10%↑ Y/Y)
Back